Aspirin and Subarachnoid Haemorrhage in the UK Biobank
- 9 July 2022
- journal article
- research article
- Published by Springer Nature in Translational Stroke Research
- Vol. 14 (4) , 490-498
Abstract
Previous studies investigating the relationship between aspirin use and subarachnoid haemorrhage (SAH) have yielded conflicting results. In this study, we aimed to clarify the association between aspirin and SAH in the general population. The UK Biobank is a prospective population-based cohort study. Sex, age, smoking, alcohol, medication use, hypertension, blood pressure, ischaemic heart disease and stroke were recorded at baseline assessments. Follow-up is conducted through linkages to National Health Service data including electronic, coded death certificate, hospital and primary care data. Cox proportional hazards modelling was used to analyse the association between aspirin use and SAH. Of the 501,060 participants included in the analysis, a total of 579 suffered from spontaneous SAH after their baseline assessment. There was no relationship between aspirin and SAH of all causes (HR, 1.16 [0.92–1.46]), aneurysmal SAH (HR, 1.15 [0.91–1.47]) or non-aneurysmal SAH (HR, 1.29 [0.54–3.09]). Aspirin use was associated with SAH resulting in death (HR, 1.69 [1.14–2.51]), especially out of hospital death (HR, 2.10 [1.13–3.91]). Despite reports of a protective association between aspirin and SAH in patients with known unruptured aneurysms, this study has not demonstrated the same effect in the general population. However, aspirin users were more likely to suffer SAH resulting in death, especially out of hospital.Keywords
Funding Information
- NIHR Oxford Biomedical Research Centre
This publication has 26 references indexed in Scilit:
- Antithrombotic drugs and risk of hemorrhagic stroke in the general populationNeurology, 2013
- Biology of Intracranial Aneurysms: Role of InflammationJournal of Cerebral Blood Flow & Metabolism, 2012
- Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm RuptureStroke, 2011
- Lack of Complement Inhibitors in the Outer Intracranial Artery Aneurysm Wall Associates with Complement Terminal Pathway ActivationThe American Journal of Pathology, 2010
- Antiplatelet drugs and risk of subarachnoid hemorrhage: a population‐based case‐control studyJournal of Thrombosis and Haemostasis, 2010
- Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trendsJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Matrix metalloproteinases 2 and 9 in human atherosclerotic and non‐atherosclerotic cerebral aneurysmsEuropean Journal of Neurology, 2006
- Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled TrialsThe American Journal of Medicine, 2006
- Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in manNature, 1985
- Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man.British Journal of Clinical Pharmacology, 1979